Tips and tricks from our application experts: AAV analysis with CE

Jan 24, 2025 | Biopharma, BioPhase 8800 system, Blogs, PA 800 system | 0 comments

Read time: 2 minutes

Peter Holper, Staff Applications Scientist at SCIEX, US, shares his tips and tricks on AAV analysis using CE with the BioPhase 8800 system and the PA 800 Plus system.

Tip 1: Leverage the flexibility in injection modes

When starting out with a new viral vector product, my recommendation is to compare three different modes of injection using UV detection. First, start with a standard electrokinetic injection, which allows for the highest theoretical resolution. Next, use a pressure/ hydrodynamic injection, which will inject the same plug regardless of sample ionic strength and provide a quick estimate of the titer. Finally, use a field-amplified sample stacking (FASS) injection to achieve the highest sensitivity, while understanding it is the most sensitive injection method to the ionic strength of the matrix. Comparing these three peak profiles can give significant insight into the optimal separation conditions for each molecule analyzed.

Tip 2: Deal with low sample amounts

During early-stage development of AAV vectors, oftentimes only a few micrograms of proteins or less are available for analytics. However, most analytical technology is not practical for applications with low protein concentration or small sample volumes. To improve the sensitivity of CE-SDS, my recommendation is to use laser-induced fluorescence (LIF) detection instead of UV absorbance. Comparing the results from the different injection types (tip 1) will help you determine if additional sensitivity and transition to LIF detection is needed.

Tip 3: Optimize fluorescence dye labelling

Labeling procedure can pose challenges and require optimization for each product. Currently, the most common fluorescent dye used in CE-SDS-LIF is Chromeo P503, which has a low quantum yield when not bound to a protein and thus does not require additional cleanup after conjugation. When optimizing the labeling procedure with Chromeo P503, I find the dye-to-protein ratio to be the most important factor. If this ratio is not optimal, low signal or high peak tailing is often observed. I find that estimating the protein titer by referring to the peak area achieved with pressure injection (tip 1) can be highly beneficial, since only the genome titer may be known at this point.

Celebrating customer experience: Insights from SCIEX leaders

Customer Experience Day (CX Day) is a special occasion for SCIEX, celebrated every first Tuesday in October. It’s a day dedicated to recognizing the incredible value of our customers and the relentless dedication of our associates who strive to make every interaction meaningful. At SCIEX, our commitment to customer experience is woven into the fabric of everything we do. From providing cutting-edge solutions to offering unwavering support, we aim to build lasting relationships and exceed expectations. Join us as we delve into the insights from our leaders on what customer experience means to SCIEX and how it shapes our journey.

Why traditional MS/MS falls short for ADCs and how electron-activated dissociation (EAD) changes the equation

Antibody-drug conjugates (ADCs) are among the most promising—and analytically demanding—modalities in biopharma today. By combining large, heterogeneous antibodies with chemically labile payloads and linkers, ADCs introduce a level of structural complexity that challenges conventional analytical workflows. It also poses the challenge that the very features you need to measure are often the easiest to lose during analysis.

Six benefits of remote support every laboratory should know

Imagine having a tech expert at your fingertips to solve computer issues or a fitness trainer guiding you through workouts from the comfort of your home. In today’s fast-paced world, the ability to provide and receive service and support remotely is no longer a luxury but a necessity. Whether it’s troubleshooting a software issue, repairing a device, offering customer assistance, or enjoying the convenience of telehealth as a private individual, remote capabilities have revolutionized how businesses operate and how individuals get help

Posted by

Peter Holper has over 15 years of experience in biopharma, including his role as an analytical chemist at Eli Lilly and Company where he was responsible for developing the analytical control strategy for bioproducts. He has extensive experience in analytical method development for biologics and held various positions with increasing responsibility. Peter currently works at SCIEX as a Staff Applications Scientist in Redwood City, California, where he is responsible for developing and optimizing CE applications and providing customer demo sample analysis support.

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network